Results 61 to 70 of about 5,830,231 (212)
Comparative studies between HTLV-1 and HTLV-2 function and pathobiology
, 2015 Human T-cell leukemia viruses type 1 and 2 (HTLV-1 and HTLV-2) share a common genetic organization, expression strategy and ability to infect and immortalize T-cells in vitro; however, HTLV-1 and HTLV-2 are strikingly different in terms of clinical ...
Francoise Bex +3 more
core +1 more source
MedComm, Volume 7, Issue 9, September 2026.Microbial signals from gut and tumor‐resident bacteria, fungi, viruses, and bacteriophages reshape immune and metabolic networks within the tumor microenvironment, thereby influencing cancer progression, treatment response. Therapeutic modulations, including dietary interventions, probiotics, antibiotics, fecal microbiota transplantation, engineered ...
Juan Lu +8 more
wiley +1 more source
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors
, 1991 The clinical significance of human T-cell lymphotropic virus type II (HTLV-II) infection, unlike that of HTLV-I, is unknown, and the major known association of HTLV-II seropositivity is with intravenous drug abuse.
Swanson, P +10 more
core +1 more source
Biomédica: revista del Instituto Nacional de Salud, 2018 Introduction: The human-T cell lymphotropic virus is a retrovirus with various types known so far. HTLV-I and HTLV-II are of clinically importance as they cause different diseases such as adult T-cell leukemia/lymphoma, tropical spastic paraparesis, and ...
Manuela Muñoz +4 more
doaj +1 more source
Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 5, September 2026.ABSTRACT With the recent introduction of the European Union's Packaging and Packaging Waste Regulation (PPWR) in February 2025, reusable plastic packaging schemes have gained increasing attention as a more circular and sustainable alternative to single‐use plastics (SUPs).
Ronan Farrell +3 more
wiley +1 more source
PREVALENCE OF ANTI-HTLV-I/II IN SLOVENIAN BLOOD DONORS AND THEIMPACT ON BLOOD SCREENING
Zdravniški Vestnik, 2008 BACKGROUND Human T-limphotropic viruses type I and II are retroviruses. People infected withHTLV-I/II are usually asymptomatic, lifelong antibodies carriers. Transfusion of blood components is one of the modes of virus transmissions.
Petra Jovanovič +1 more
doaj
Getting to the Heart of Health Education With Lessons My Students Taught Me
Journal of School Health, Volume 96, Issue 10, October 2026.
Stephen Sroka
wiley +1 more source
Integrated Engineering of CAR‐T Cells for Solid Tumours
Cell Proliferation, Volume 59, Issue 9, September 2026.Solid tumours pose multifactorial barriers including antigen heterogeneity, immunosuppressive microenvironment, and poor T‐cell trafficking, limiting CAR‐T efficacy compared to hematologic malignancies. Integrated engineering strategies are essential, combining logic‐gated receptors for precision, metabolic‐epigenetic reprogramming for resilience, and ...
Chao Yang +5 more
wiley +1 more source
Molecular Cancer, 2010 Background Human T-cell leukemia virus type I (HTLV-I) has efficiently adapted to its host and establishes a persistent infection characterized by low levels of viral gene expression and slow proliferation of HTLV-I infected cells over decades.
Bai XueTao +3 more
doaj +1 more source
, 2018 Subjects with chronic airways disease were examined by chest high resolution computed tomography. Median (IQR) HTLV-1c pVL for subjects with bronchiolitis/bronchitis (2.69 (0.82, 3.43) log10 copies per 105 PBL) and bronchiectasis (2.69 (1.57, 3.49) log10
Charles Bangham (3429920) +7 more
core +1 more source